Rudolf Hausmann

Prof. Dr. Rudolf Hausmann

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2012 in Process Biochemistry
Verified
Journal Article
Closed access
MHMarius Henkel
Marius Henkel
MMMarkus M. Müller
Markus M. Müller
JKJohannes H. Kügler
Johannes H. Kügler
RLRoberta B. Lovaglio
Roberta B. Lovaglio
JCJonas Contiero
Jonas Contiero
RHRudolf Hausmann
Rudolf Hausmann

1 December 2012 in Journal of Biotechnology
Verified
Journal Article
Closed access
MMMarkus Michael Müller
Markus Michael Müller
JKJohannes H. Kügler
Johannes H. Kügler
MHMarius Henkel
Marius Henkel
MGMelanie Gerlitzki
Melanie Gerlitzki
BHBarbara Hörmann
Barbara Hörmann
RHRudolf Hausmann
Rudolf Hausmann

1 January 2010
Verified
Book Chapter
Closed access
PDF file
VWVanessa Walter
Vanessa Walter
CSChristoph Syldatk
Christoph Syldatk
RHRudolf Hausmann
Rudolf Hausmann

17 October 2011 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
AWAndreas Wittgens
Andreas Wittgens
TTTill Tiso
Till Tiso
TATorsten T Arndt
Torsten T Arndt
PWPamela Wenk
Pamela Wenk
JHJohannes Hemmerich
Johannes Hemmerich
Lars M. BlankLars M. Blank
Lars M. Blank
Background: Rhamnolipids are potent biosurfactants with high potential for industrial applications. However, rhamnolipids are currently produced with the opportunistic pathogen Pseudomonas aeruginosa during growth on hydrophobic substrates such as plant oils. The heterologous production of rhamnolipids entails two essential advantages: Disconnecting the rhamnolipid biosynthesis from the complex quorum sensing regulation and the opportunity of avoiding pathogenic production strains, in particular P. aeruginosa. In addition, separation of rhamnolipids from fatty acids is difficult and hence costly. Results: Here, the metabolic engineering of a rhamnolipid producing Pseudomonas putida KT2440, a strain certified as safety strain using glucose as carbon source to avoid cumbersome product purification, is reported. Notably, P. putida KT2440 features almost no changes in growth rate and lag-phase in the presence of high concentrations of rhamnolipids (> 90 g/L) in contrast to the industrially important bacteria Bacillus subtilis, Corynebacterium glutamicum, and Escherichia coli. P. putida KT2440 expressing the rhlAB-genes from P. aeruginosa PAO1 produces mono-rhamnolipids of P. aeruginosa PAO1 type (mainly C10:C10). The metabolic network was optimized in silico for rhamnolipid synthesis from glucose. In addition, a first genetic optimization, the removal of polyhydroxyalkanoate formation as competing pathway, was implemented. The final strain had production rates in the range of P. aeruginosa PAO1 at yields of about 0.15 g/gglucose corresponding to 32% of the theoretical optimum. What's more, rhamnolipid production was independent from biomass formation, a trait that can be exploited for high rhamnolipid production without high biomass formation. Conclusions: A functional alternative to the pathogenic rhamnolipid producer P. aeruginosa was constructed and characterized. P. putida KT24C1 pVLT31_rhlAB featured the highest yield and titer reported from heterologous rhamnolipid producers with glucose as carbon source. Notably, rhamnolipid production was uncoupled from biomass formation, which allows optimal distribution of resources towards rhamnolipid synthesis. The results are discussed in the context of rational strain engineering by using the concepts of synthetic biology like chassis cells and orthogonality, thereby avoiding the complex regulatory programs of rhamnolipid production existing in the natural producer P. aeruginosa.

9 March 2010 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
MMMarkus Michael Müller
Markus Michael Müller
MMMarkus Michael
Markus Michael
BHBarbara Hörmann
Barbara Hörmann
CSChristoph Syldatk
Christoph Syldatk
RHRudolf Hausmann
Rudolf Hausmann

3 May 2013 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Closed access
PDF file
HAHossein Amani
Hossein Amani
MMMarkus Michael Müller
Markus Michael Müller
CSChristoph Syldatk
Christoph Syldatk
RHRudolf Hausmann
Rudolf Hausmann